{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:36:13Z","timestamp":1788068173939,"version":"build-2784847793"},"reference-count":106,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.autrev.2023.103443","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T01:52:55Z","timestamp":1694224375000},"page":"103443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["SpA plus IBD or IBD plus SpA: Does commutative property apply?"],"prefix":"10.1016","volume":"22","author":[{"given":"Francesco","family":"Carubbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Viscido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Maria","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Di Ruscio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001558","article-title":"The arthritis connection to inflammatory bowel disease (IBD): Why has it taken so long to understand it?","volume":"7","author":"Ashrafi","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.autrev.2023.103443_bb0010","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(02)05560-5","article-title":"Colitis","volume":"145","author":"Hale","year":"1895","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103443_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000658-192210000-00016","article-title":"Treatment of rheumatoid arthritis by colectomy","volume":"76","author":"Smith","year":"1922","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/0003-4819-3-4-335","article-title":"Complications and sequelae of chronic ulcerative colitis","volume":"3","author":"Bargen","year":"1929","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0025","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9343(62)90223-1","article-title":"Arthritis accompanying ulcerative colitis","volume":"33","author":"McEwen","year":"1962","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.23.1.64","article-title":"Arthritic manifestations in regional enteritis","volume":"23","author":"Ansell","year":"1964","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.1780210603","article-title":"Seronegative polyarthritis: A unified concept","volume":"21","author":"Wright","year":"1978","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0045","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0050","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2023.103443_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1759720X18773726","article-title":"Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria","volume":"10","author":"Proft","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9","key":"10.1016\/j.autrev.2023.103443_bb0070","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/acr.22016","volume":"65","author":"Molt\u00f3","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2023.103443_bb0075","doi-asserted-by":"crossref","DOI":"10.1177\/17562848221115312","article-title":"Inflammatory bowel disease and immune-mediated inflammatory diseases: Looking at the less frequent associations","volume":"15","author":"Bezzio","year":"2022","journal-title":"Ther Adv Gastroenterol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0080","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0085","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/eci.13.26","article-title":"Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS","volume":"9","author":"Carubbi","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0090","doi-asserted-by":"crossref","first-page":"102457","DOI":"10.1016\/j.autrev.2019.102457","article-title":"Enteropathic spondyloarthritis: Results from a large nationwide database analysis","volume":"19","author":"Picchianti-Diamanti","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0095","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/ibd\/izab269","article-title":"Enteropathic arthritis beyond the criteria","volume":"28","author":"\u0130lgen","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nrgastro.2013.117","article-title":"Extraintestinal manifestations and complications in IBD","volume":"10","author":"Ott","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.autrev.2023.103443_bb0115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/acr.23468","article-title":"Association of comorbidities in Spondyloarthritis with poor function, work disability, and quality of life: results from the assessment of SpondyloArthritis international society comorbidities in Spondyloarthritis study","volume":"70","author":"Nikiphorou","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ibd\/izz105","article-title":"The impact of Spondyloarthritis and joint symptoms on health-related quality of life and fatigue in IBD patients. Results from a population-based inception cohort (20-year follow-up in the Ibsen study)","volume":"26","author":"Ossum","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.autrev.2023.103443_bb0125","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.autrev.2014.04.003","article-title":"Italian expert panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease","volume":"13","author":"Olivieri","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2023.103443_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ecco-jcc\/jjv067","article-title":"Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn\u2019s disease: an IOIBD initiative","volume":"9","author":"Danese","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reuma.2017.07.001","article-title":"Screening of inflammatory bowel disease and Spondyloarthritis for referring patients between rheumatology and gastroenterology","volume":"14","author":"Sanz Sanz","year":"2018","journal-title":"Reumatol Clin"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cei.13246","article-title":"Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis","volume":"196","author":"Felice","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0145","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3899\/jrheum.130048","article-title":"Development, sensibility, and reliability of the Toronto axial Spondyloarthritis questionnaire in inflammatory bowel disease","volume":"40","author":"Alnaqbi","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103443_bb0150","doi-asserted-by":"crossref","first-page":"8618703","DOI":"10.1155\/2018\/8618703","article-title":"Performance of two screening questionnaires for inflammatory arthritis in patients with inflammatory bowel disease","volume":"2018","author":"Queiro","year":"2018","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0155","first-page":"755","article-title":"Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice","volume":"54","author":"Gomoll\u00f3n","year":"2022","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0160","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/00365521.2019.1668052","article-title":"Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients","volume":"54","author":"Ribaldone","year":"2019","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103443_bb0165","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/ecco-jcc\/jjaa096","article-title":"The IBIS-Q [IBd identification of Spondyloarthritis questionnaire]: A novel tool to detect both axial and peripheral arthritis in inflammatory bowel disease patients","volume":"14","author":"Variola","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0170","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10067-017-3937-6","article-title":"The DETection of arthritis in inflammatory boweL diseases (DETAIL) questionnaire: Development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis","volume":"37","author":"Di Carlo","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3899\/jrheum.200364","article-title":"Multicenter validation of the DETAIL questionnaire for the screening of Spondyloarthritis in patients with inflammatory bowel diseases","volume":"48","author":"Benfaremo","year":"2021","journal-title":"J Rheumatol"},{"issue":"11\u201312","key":"10.1016\/j.autrev.2023.103443_bb0180","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/apt.15519","article-title":"Expert consensus: Practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies","volume":"50","author":"Varkas","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00054725-200411000-00009","article-title":"A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease","volume":"10","author":"Bonner","year":"2004","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0190","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","article-title":"Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease","volume":"50","author":"Long","year":"2016","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0195","first-page":"203","article-title":"Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study","volume":"4","author":"Sandborn","year":"2006","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","article-title":"The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases","volume":"101","author":"El Miedany","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/apt.15589","article-title":"Editorial: Establishing a joint approach to a common problem for gastroenterologists","volume":"51","author":"Luber","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0210","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1093\/rheumatology\/keaa036","article-title":"Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain","volume":"59","author":"Martinis","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.autrev.2023.103443_bb0215","doi-asserted-by":"crossref","first-page":"919521","DOI":"10.3389\/fmed.2022.919521","article-title":"Musculoskeletal ultrasound to identify subclinical joint and periarticular involvement in patients with inflammatory bowel disease: A systematic literature review","volume":"9","author":"Sakellariou","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2023.103443_bb0220","doi-asserted-by":"crossref","first-page":"637459","DOI":"10.3389\/fmed.2021.637459","article-title":"High prevalence of ultrasound verified Enthesitis in patients with inflammatory bowel disease with or without Spondylarthritis","volume":"8","author":"Husic","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2023.103443_bb0225","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fmed.2018.00290","article-title":"The impact of fibromyalgia in Spondyloarthritis: From classification criteria to outcome measures","volume":"5","author":"Alunno","year":"2018","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0230","first-page":"1167","article-title":"Fibromyalgia in inflammatory bowel disease","volume":"26","author":"Buskila","year":"1999","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0235","first-page":"590","article-title":"Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: A cross sectional population survey","volume":"28","author":"Palm","year":"2001","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis--Beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0245","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/acr.24174","article-title":"The phenotype of axial Spondyloarthritis: Is it dependent on HLA-B27 status?","volume":"73","author":"Coates","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0250","first-page":"518","article-title":"Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn\u2019s disease","volume":"30","author":"Steer","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ecco-jcc\/jjx126","article-title":"Ankylosing spondylitis and axial Spondyloarthritis in patients with Long-term inflammatory bowel disease: Results from 20 years of follow-up in the IBSEN study","volume":"12","author":"Ossum","year":"2018","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0260","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003179","article-title":"Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: Results from ASAS-PerSpA study","volume":"9","author":"Chaudhary","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1440-1746.2007.05108.x","article-title":"Clinical and genetic factors associated with sacroiliitis in Crohn\u2019s disease","volume":"23","author":"Peeters","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"18","key":"10.1016\/j.autrev.2023.103443_bb0270","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.3748\/wjg.v25.i18.2162","article-title":"Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment","volume":"25","author":"Fragoulis","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0275","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","article-title":"Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease","volume":"118","author":"Orchard","year":"2000","journal-title":"Gastroenterology."},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2023.103443_bb0280","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/ibd.20726","article-title":"Do HLA antigens predict the occurrence of extraintestinal manifestations of IBD?","volume":"14","author":"Jewell","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2023.103443_bb0285","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1521-6918(11)70006-3","article-title":"Novel development in extraintestinal manifestations and spondylarthropathy","volume":"25","author":"De Vos","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0290","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/art.10329","article-title":"Role of NOD2 variants in spondylarthritis","volume":"46","author":"Crane","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0295","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/ard.2004.028837","article-title":"CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn\u2019s disease","volume":"64","author":"Laukens","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103443_bb0300","doi-asserted-by":"crossref","first-page":"8630871","DOI":"10.1155\/2019\/8630871","article-title":"Biomarkers in inflammatory bowel disease-associated Spondyloarthritis: State of the art and unmet needs","volume":"2019","author":"Benfaremo","year":"2019","journal-title":"J Immunol Res"},{"issue":"11","key":"10.1016\/j.autrev.2023.103443_bb0305","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/1744666X.2021.1991315","article-title":"Inflammatory bowel disease manifestations in spondyloarthritis: Considerations for the clinician","volume":"17","author":"Lubrano","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060866","article-title":"Gene polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in patients with Crohn\u2019s disease: On the way to personalized medicine?","volume":"12","author":"Hoffmann","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1573397114666180320113603","article-title":"Laboratory assessment of patients with suspected rheumatic musculoskeletal diseases: Challenges and pitfalls","volume":"15","author":"Carubbi","year":"2019","journal-title":"Curr Rheumatol Rev"},{"issue":"7","key":"10.1016\/j.autrev.2023.103443_bb0320","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/ard.2009.120139","article-title":"Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis","volume":"69","author":"Poddubnyy","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2023.103443_bb0325","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24838","article-title":"Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis","volume":"61","author":"de Vries","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103443_bb0330","first-page":"73","article-title":"Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sj\u00f6gren\u2019s syndrome","volume":"36","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.62.5.455","article-title":"Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy","volume":"62","author":"Hoffman","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000080081","article-title":"Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA","volume":"70","author":"T\u00f6r\u00f6k","year":"2004","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0345","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: A reassessment","volume":"47","author":"Aydin","year":"2008","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0350","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: An observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.autrev.2023.103443_bb0355","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3899\/jrheum.100269","article-title":"pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease","volume":"37","author":"de Vries","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai","year":"2023","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0365","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103443_bb0370","doi-asserted-by":"crossref","first-page":"106948","DOI":"10.1016\/j.intimp.2020.106948","article-title":"Calprotectin in spondyloarthritis: A systematic review and meta-analysis","volume":"88","author":"Ma","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0375","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3899\/jrheum.161216","article-title":"Detection of Crohn disease in patients with Spondyloarthropathy: The SpACE capsule study","volume":"45","author":"Kopylov","year":"2018","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009742.2017.1299216","article-title":"Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis","volume":"47","author":"\u00d8stg\u00e5rd","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0385","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ecco-jcc\/jjz205","article-title":"Faecal calprotectin for the diagnosis of bowel inflammation in patients with Rheumatological diseases: A systematic review","volume":"14","author":"Fauny","year":"2020","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0390","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar3857","article-title":"Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis","volume":"14","author":"Mattey","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0395","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/ar4106","article-title":"Markers of intestinal inflammation in patients with ankylosing spondylitis: A pilot study","volume":"14","author":"Matzkies","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0400","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10067-021-05968-1","article-title":"Biomarkers in axial spondyloarthritis and low back pain: A comprehensive review","volume":"41","author":"Reveille","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0405","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/ecco-jcc\/jjac065","article-title":"Association between inflammatory bowel disease and Spondyloarthritis: Findings from a Nationwide study in Sweden","volume":"16","author":"Shrestha","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"20","key":"10.1016\/j.autrev.2023.103443_bb0410","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3748\/wjg.15.2449","article-title":"Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease","volume":"15","author":"Salvarani","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103443_bb0415","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.150628","article-title":"Inflammatory bowel diseases and Spondyloarthropathies","volume":"93","author":"Gionchetti","year":"2015","journal-title":"J Rheumatol Suppl"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10620-010-1260-z","article-title":"Peripheral arthritis in the course of inflammatory bowel diseases","volume":"56","author":"Y\u00fcksel","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.autrev.2023.103443_bb0425","first-page":"631","article-title":"The prevalence and incidence of axial and peripheral Spondyloarthritis in inflammatory bowel disease: A systematic review and meta-analysis","volume":"11","author":"Karreman","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001777","article-title":"Spondyloarthritis in inflammatory bowel disease cohorts: Systematic literature review and critical appraisal of study designs","volume":"8","author":"Schwartzman","year":"2022","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2023.103443_bb0435","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103443_bb0440","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X21996973","article-title":"Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review","volume":"13","author":"Evans","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0445","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/rheumatology\/keac473","article-title":"Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: Secondary care cross-sectional study","volume":"62","author":"Lim","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0450","first-page":"511","article-title":"Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: A population study (the IBSEN study)","volume":"29","author":"Palm","year":"2002","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2023.103443_bb0455","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3899\/jrheum.161518","article-title":"Case-control study on Dactylitis, Enthesitis, and anterior uveitis in Spondyloarthritis associated with inflammatory bowel diseases: Role of coexistent psoriasis","volume":"44","author":"Cantini","year":"2017","journal-title":"J Rheumatol"},{"issue":"28","key":"10.1016\/j.autrev.2023.103443_bb0460","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004267","article-title":"Clinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.autrev.2023.103443_bb0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1572-0241.2004.04039.x","article-title":"Cigarette smoking and appendectomy are risk factors for extraintestinal manifestations in ulcerative colitis","volume":"99","author":"Manguso","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.autrev.2023.103443_bb0475","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: A population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0480","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","article-title":"The early disease stage in axial spondylarthritis: Results from the German Spondyloarthritis inception cohort","volume":"60","author":"Rudwaleit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2023.103443_bb0485","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-016-1093-z","article-title":"Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: A meta-analysis","volume":"18","author":"de Winter","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0490","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jbspin.2011.01.013","article-title":"The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients","volume":"78","author":"Dougados","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.autrev.2023.103443_bb0495","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/rheumatology\/keu388","article-title":"Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS","volume":"54","author":"Essers","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0500","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: Results from the GIANT cohort","volume":"73","author":"Van Praet","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2023.103443_bb0505","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00296-022-05117-0","article-title":"Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis","volume":"42","author":"Ono","year":"2022","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0510","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: A multiparametric predictive model","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2023.103443_bb0515","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/gast.1996.v110.pm8964393","article-title":"Long-term evolution of gut inflammation in patients with spondyloarthropathy","volume":"110","author":"De Vos","year":"1996","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.autrev.2023.103443_bb0520","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103443_bb0525","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3899\/jrheum.180135","article-title":"The role of the microbiome in gut and joint inflammation in psoriatic arthritis and Spondyloarthritis","volume":"94","author":"Gilis","year":"2018","journal-title":"J Rheumatol Suppl"},{"issue":"3","key":"10.1016\/j.autrev.2023.103443_bb0530","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2468-1253(21)00297-1","article-title":"Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: The EXTRA consensus from the International Organization for the Study of inflammatory bowel diseases","volume":"7","author":"Guillo","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:27:36Z","timestamp":1761600456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1568997223001775"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103443","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SpA plus IBD or IBD plus SpA: Does commutative property apply?","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103443"}}